Steris (STE) Liabilities from Discontinued Operations (2023 - 2024)
Steris (STE) posted quarterly Liabilities from Discontinued Operations of 64012000.0 for Q1 2024, up 26.4% year-over-year from 50642000.0 in Q2 2023, and up 26.4% quarter-over-quarter from 50642000.0 in Q1 2023.
Steris (STE) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends
Steris' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 64012000.0 for Q1 2024.
- In Q1 2024, Liabilities from Discontinued Operations rose 26.4% year-over-year to 64012000.0; the TTM figure through Mar 2024 stood at 64012000.0 (up 26.4% YoY), while the FY2024 annual figure was 64012000.0, up 26.4% from the prior year.
- Liabilities from Discontinued Operations for Q1 2024 stood at 64012000.0, up from 50642000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 64012000.0 in Q1 2024, with the low at 50642000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.08 Bn | 4.50 Bn |
| 3 | Medtronic | 120.09 Bn | 110.87 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.80 Bn | 73.26 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 64.01 Mn |
| Mar 31, 2024 | 64.01 Mn |
| Mar 31, 2023 | 50.64 Mn |
| Mar 31, 2023 | 50.64 Mn |